Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 Please take the same on your records Dr. Ashish V. Rawandale Managing Director DIN:- 02005733 Ref: CAM/2025 03rd January, 2025 The Company Secretary Tejnaksh Healthcare Ltd. Hospital Divn., Institute of Urology Sakri Road Dhule 424001. Subject: Certificate under Regulation 74(5) of Securities and Exch
Tejnaksh Healthcare Ltd. on 6ix
Earlier from Tejnaksh Healthcare
- Tejnaksh Healthcare Ltd. Press Release Nov 14 2024
- Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2024.
- Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015
- Tejnaksh Healthcare Ltd. Press Release Nov 07 2024
- Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations, 2015 And ClosureOf Trading Window
Later from Tejnaksh Healthcare
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd January, 2025 Under Regulation 30 OfThe SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Tejnaksh Healthcare Ltd. Press Release Jan 23 2025
- Extra Ordinary General Meeting (''EOGM'') Of The Members Of Tejnaksh Healthcare Limited Is Scheduled To Be Held On Saturday, The 22Nd February, 2025 At 3.00 Pm (IST) Through Two-Way Video Conferencing (''VC'') Facility / Other Audio Visual Means (''O
- Tejnaksh Healthcare Ltd. Press Release Jan 30 2025
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And Closure Of Trading Window
Follow Tejnaksh Healthcare into a list and get an email when it puts out news.
Follow Tejnaksh Healthcare